Skip to main content

Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine.

Publication ,  Conference
Silverman, LR; McKenzie, DR; Peterson, BL; De Castro, CM; Ellerton, J; Knapp, KN; Beach, CL; Larson, RA
Published in: BLOOD
November 16, 2005

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2005

Volume

106

Issue

11

Start / End Page

709A / 709A

Location

Atlanta, GA

Publisher

AMER SOC HEMATOLOGY

Conference Name

47th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Silverman, L. R., McKenzie, D. R., Peterson, B. L., De Castro, C. M., Ellerton, J., Knapp, K. N., … Larson, R. A. (2005). Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine. In BLOOD (Vol. 106, pp. 709A-709A). Atlanta, GA: AMER SOC HEMATOLOGY.
Silverman, L. R., D. R. McKenzie, B. L. Peterson, C. M. De Castro, J. Ellerton, K. N. Knapp, C. L. Beach, and R. A. Larson. “Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine.” In BLOOD, 106:709A-709A. AMER SOC HEMATOLOGY, 2005.
Silverman LR, McKenzie DR, Peterson BL, De Castro CM, Ellerton J, Knapp KN, et al. Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine. In: BLOOD. AMER SOC HEMATOLOGY; 2005. p. 709A-709A.
Silverman, L. R., et al. “Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine.BLOOD, vol. 106, no. 11, AMER SOC HEMATOLOGY, 2005, pp. 709A-709A.
Silverman LR, McKenzie DR, Peterson BL, De Castro CM, Ellerton J, Knapp KN, Beach CL, Larson RA. Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine. BLOOD. AMER SOC HEMATOLOGY; 2005. p. 709A-709A.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2005

Volume

106

Issue

11

Start / End Page

709A / 709A

Location

Atlanta, GA

Publisher

AMER SOC HEMATOLOGY

Conference Name

47th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology